Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale Di Legnano
Clinical trials sponsored by Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale Di Legnano, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Bioactive glass could ease ear surgery After-Effects Results expected May 2027 (estimated)
-
Botox injection before hernia surgery may reduce need for risky muscle cuts
Disease control By invitation onlyThis Italian study tests whether injecting Botulinum Toxin A (Botox) into the abdominal muscles weeks before surgery can relax them, making it easier to close large hernias. Researchers will measure changes in CT scans and see if this reduces the need for complex surgical techniq…
Phase 2 • Sponsor: Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Bioactive glass could ease ear surgery After-Effects
Symptom relief By invitation onlyThis study tests whether using bioactive glass granules during a second ear surgery can improve quality of life for people with ongoing problems like discharge, dizziness, or trouble using hearing aids. Fifty adults who had prior ear surgery will receive the procedure and be foll…
Sponsor: Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Frailty check could predict chemo danger for seniors
Knowledge-focused By invitation onlyThis study looks at how frailty—a state of weakness and reduced physical function—affects the risk of severe side effects from chemotherapy in people aged 70 and older with cancer. Researchers will assess 160 patients using various tests for frailty, muscle loss, and overall heal…
Sponsor: Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC